ArticleEnvironment international2026
Shaping the future of human biomonitoring (HBM): progress, strategy, and global vision from ISES Europe and the HBM Global Network.
Article in Environment international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Bibliometric Review and Knowledge Mapping of Microplastics and Nanoplastics in Cardiovascular Research.Cardiovascular toxicology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
38 authors.
Funding
Abstract
Human biomonitoring (HBM) continues to play an indispensable role within exposure science, offering insights into aggregate chemical exposures across populations and life stages. Since 2018, the European chapter of the International Society of Exposure Science Human Biomonitoring Working Group (ISES Europe HBM WG) has aimed to facilitate generation of more and high-quality HBM data. The working group aims to strengthen integration of HBM data into regulatory frameworks through improved study design, harmonized methodologies, and enhanced reporting practices. Key achievements in the past seven years include the harmonization of HBM metadata through development of minimum information requirements for HBM (MIR-HBM), development of chemical-specific BASIC Guides for occupational health and hygiene professionals, and establishment of the FAIR (Findable, Accessible, Interoperable, and Reusable) Environmental and Health Registry (FAIREHR) to enhance data transparency and reusability. Recognizing the need for broader impact, the HBM Global Network was launched in 2025 to promote worldwide collaboration, capacity building, and policy integration. Together, ISES Europe HBM WG and the HBM Global Network form a coordinated platform with shared governance, strategic priorities, and digital infrastructure. This short communication outlines the progress to date, strategic pillars guiding our work, and ongoing initiatives linking science, policy, and practice. We call on researchers, regulators, and stakeholders worldwide to join these networks, strengthen harmonized approaches, and ensure that HBM becomes a cornerstone of 21st-century chemical risk governance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.